Dimitris Voliotis - Jan 18, 2022 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
/s/ Melissa B. Epperly, Attorney-in-Fact for Dimitris Voliotis
Stock symbol
ZNTL
Transactions as of
Jan 18, 2022
Transactions value $
-$1,300,745
Form type
4
Date filed
1/20/2022, 06:15 PM
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Options Exercise $180K +10K +160% $18.00 16.3K Jan 18, 2022 Direct F1
transaction ZNTL Common Stock Sale -$210K -3.41K -20.98% $61.70 12.8K Jan 18, 2022 Direct F1, F2
transaction ZNTL Common Stock Sale -$205K -3.29K -25.65% $62.34 9.55K Jan 18, 2022 Direct F1, F3
transaction ZNTL Common Stock Sale -$127K -2K -20.92% $63.48 7.55K Jan 18, 2022 Direct F1, F4
transaction ZNTL Common Stock Sale -$84.1K -1.3K -17.22% $64.66 6.25K Jan 18, 2022 Direct F1, F5
transaction ZNTL Common Stock Options Exercise $180K +10K +160% $18.00 16.3K Jan 19, 2022 Direct F1
transaction ZNTL Common Stock Sale -$478K -7.89K -48.55% $60.55 8.36K Jan 19, 2022 Direct F1, F6
transaction ZNTL Common Stock Sale -$95.7K -1.56K -18.61% $61.51 6.81K Jan 19, 2022 Direct F1, F7
transaction ZNTL Common Stock Sale -$34.5K -555 -8.16% $62.24 6.25K Jan 19, 2022 Direct F1, F8
transaction ZNTL Common Stock Options Exercise $180K +10K +160% $18.00 16.3K Jan 20, 2022 Direct F1
transaction ZNTL Common Stock Sale -$505K -8.34K -51.34% $60.52 7.91K Jan 20, 2022 Direct F1, F9
transaction ZNTL Common Stock Sale -$101K -1.66K -20.96% $61.21 6.25K Jan 20, 2022 Direct F1, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZNTL Stock Option Options Exercise $0 -10K -6.45% $0.00 145K Jan 18, 2022 Common Stock 10K $18.00 Direct F1, F11
transaction ZNTL Stock Option Options Exercise $0 -10K -6.9% $0.00 135K Jan 19, 2022 Common Stock 10K $18.00 Direct F1, F11
transaction ZNTL Stock Option Options Exercise $0 -10K -7.41% $0.00 125K Jan 20, 2022 Common Stock 10K $18.00 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2021.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $60.97 to $61.96. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.98 to $62.93. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $63.18 to $64.02. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $64.23 to $65.19. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $60.07 to $61.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F7 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.09 to $61.94. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F8 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $62.15 to $62.41. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F9 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $60.00 to $60.95. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F10 The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $61.01 to $61.61. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F11 The option vests and becomes exercisable as to 25% of the shares on March 25, 2021 and vests in equal monthly installments thereafter until March 25, 2024.